Microbiome

Microbes (and their genes) that can be used as ingredients, therapeutics, and health biomarkers across a wide range of industries.

LUX TAKE:

This innovation area has the potential to unlock a new layer of personalization across food, personal care products, medicine, and more if science is able to define "optimal" microbiome profiles for each use case.

Data last updated on October 16, 2018

What's New

Lux Research analysts and the Lux Intelligence Engine have added the following recent microbiome developments.

News Commentaries

Glyphosate impairs disease susceptibility of honeybees through the gut microbiome (September 24, 2018)

uBiome to expand into microbiome-based therapeutics with Series C funding (September 21, 2018)

New Lux Content

Flying cars and baby formula: Highlights from the Lux Analyst Team (October 16, 2018)

Three trends in prebiotics you can't succeed without leveraging (September 18, 2018)

New Patents

Nestlé: Method for diagnosing irritable bowel syndrome

Nestlé: Pathway specific markers for diagnosing irritable bowel syndrome

New Investment Rounds

Pivot Bio has raised $70 million in Series B funding (October 2, 2018)

uBiome has raised $83 million in Series C funding (September 21, 2018)

Related companies	Metabiomics, uBiome, OpenBiome, Symbiotic Health, Computomics, Ganeden, Ganeden, BioConsortia, OptiBiotix, Blue Turtle Bio, MicroBiome Therapeutics, Growcentia, MyBiotics, AB-Biotics, DayTwo, S-Biomedic, NextFoods, Inc., Faye Face, Trace Genomics, Hidoc Technologies, Resphera Biosciences, One Codex, DoseBiome, Ixcela, Greenteaspoon

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Interested in Learning More?

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 (0) 20-3460840

For APAC (Singapore)
+65 6592-6978